Today, the Qt Companyannounced a new partnership with MedAcuity, the go-to US-based software development partner for leading MedTech companies, to help clients accelerate time-to-market for their medical device products.
ESPOO, Finland, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Today, the Qt Company (HEX: QTCOM) announced a new partnership with MedAcuity, the go-to US-based software development partner for leading MedTech companies, to help clients accelerate time-to-market for their medical device products. The partnership will leverage MedAcuity’s successful history of delivering safety-critical software engineering services to the MedTech industry, along with Qt’s highly efficient software development framework.
The medical industry, like many others, has seen tremendous change with the expansion of the Internet of Things (IoT) and the increasing number of embedded medical devices available. As a result, MedTech companies can no longer develop one device at a time; rather, they need to think about how their devices will work together to create an enhanced user experience. This complexity often requires more time for development due to issues with limited staffing and code that cannot easily be reused across multiple devices. MedAcuity, together with Qt’s cross development device framework, bridges that gap for MedTech companies.
“With the constantly changing ecosystem of the medical industry, The Qt Company’s software development framework strives to help medical device manufacturers get to market faster than ever before with the safest and most effective medical devices,” said Roger Mazzella, Senior Product Manager for The Qt Company. “Through our partnership with MedAcuity, we are combining industry-leading technology with best-in-class, ISO 13485-certified software development expertise, to deliver a complete MedTech software development framework that is second-to-none.”
“Becoming a Qt partner makes perfect sense based on where the industry’s headed, as well as Qt’s commitment to medical device regulatory standards. This alliance positions our teams to continue deliver optimal project outcomes with even greater engineering efficiency, extensibility, and maintainability for our clients,” said MedAcuity co-founder Dennis Fuccione.
Media Contacts
The Qt Company: Virpi Raski, Head of Communications, +358 45 106 5363 Virpi.Raski@qt.io
MedAcuity: Avery Adam, Marketing Coordinator, (978) 496-1912 aadam@medacuitysoftware.com
About The Qt Company
Qt Group (Nasdaq Helsinki: QTCOM) is a global software company with a strong presence in more than 70 industries and is the leading independent technology behind millions of devices and applications. Qt is used by major global companies and developers worldwide, and the technology enables its customers to deliver exceptional user experiences and advance their digital transformation initiatives. The company’s net sales in year 2017 totaled 36,3 MEUR and it employs some 300 people. To learn more, visit http://qt.io.
About MedAcuity
MedAcuity is an ISO 13485-certified custom software engineering firm focused solely on supporting the MedTech industry. Its team of over 80 full-time, senior, Massachusetts-based engineering specialists works with clients on both strategic and tactical levels to clear the most challenging hurdles and accelerate the right products to market. Through its pragmatic “special forces” approach, MedAcuity offers clients unique, practical insight, and predictable, successful business outcomes. More information is available at www.medacuitysoftware.com.
